NESS ZIONA, Israël, 28 novembre 2023 /PRNewswire/ — Une initiative exclusive de la société israélienne de biotechnologie Amorphical présente une approche révolutionnaire pour traiter diverses maladies inflammatoires et oncologiques chroniques. Développement et percée scientifiques…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.